Kirtland Hills Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,254
Closed -$440K 162
2025
Q4
$440K Sell
1,254
-20
-2% -$6.76K 0.15% 117
2025
Q3
$412K Sell
1,274
-252
-17% -$78.4K 0.16% 122
2025
Q2
$594K Sell
1,526
-198
-11% -$79.6K 0.27% 98
2025
Q1
$732K Sell
1,724
-30
-2% -$12K 0.45% 71
2024
Q4
$647K Sell
1,754
-116
-6% -$48.5K 0.41% 72
2024
Q3
$972K Sell
1,870
-57
-3% -$30.5K 0.54% 55
2024
Q2
$1.04M Sell
1,927
-31
-2% -$16.4K 0.87% 38
2024
Q1
$1.05M Buy
+1,958
New +$974K 0.9% 36

Other funds holding ELV

Kirtland Hills Capital Management's ELV Position: Q1 2026 in Review

Kirtland Hills Capital Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,254 shares — an estimated $440K sold.

Kirtland Hills Capital Management first reported a position in ELV in Q1 2024 and held it in 8 quarters. The position peaked at $1.05M in Q1 2024. 1,465 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Kirtland Hills Capital Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Kirtland Hills Capital Management sold 1,254 Elevance Health shares in Q1 2026, an estimated $440K.
  • Kirtland Hills Capital Management first reported a position in Elevance Health in Q1 2024 and held it in 8 quarters.
  • Kirtland Hills Capital Management's Elevance Health position peaked at $1.05M in Q1 2024.
  • 1,465 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Kirtland Hills Capital Management's 13F filing for Q1 2026, filed 13 May 2026.